肺腺癌组织中DTX2、PHF12表达与临床病理特征及预后的关系OA
The relationship between DTX2,PHF12 expression in lung adenocarcinoma tissue and clinical characteristics and prognosis
目的 研究肺腺癌中Deltex E3泛素连接酶2(DTX2)、PHD手指蛋白12(PHF12)表达及其与临床病理特征和预后的关系.方法 选取2020年2月—2022年2月铜川市人民医院肿瘤科收治的肺腺癌患者98例的癌组织及癌旁组织.应用R语言分析TCGA数据库中DTX2、PHF12 mRNA表达情况;采用实时荧光定量PCR和免疫组织化学法检测DTX2、PHF12 mRNA及蛋白表达;Kaplan-Meier曲线分析DTX2、PHF12蛋白表达对肺腺癌患者生存预后的影响;Cox回归分析肺腺癌患者预后的影响因素.结果 TCGA数据库分析结果显示,肺腺癌组织中DTX2、PHF12 mRNA表达高于癌旁组织(t=16.909、14.600,P均<0.001);肺腺癌组织中DTX2 mRNA表达与PHF12 mRNA表达呈正相关(r=0.566,P<0.001);肺腺癌患者癌组织DTX2、PHF12 mRNA表达高于癌旁组织(t=30.730、35.682,P均<0.001);肺腺癌患者癌组织DTX2、PHF12蛋白阳性率高于癌旁组织(x2=70.618、69.630,P均<0.001);TNM分期ⅢA期、淋巴结转移的肺腺癌患者DTX2、PHF12蛋白阳性率高于TNM分期Ⅰ~Ⅱ期、无淋巴结转移患者(x2/P=15.941、19.542、14.930、18.382,P均<0.001);DTX2、PHF12 阳性组患者的 3年无进展生存率低于阴性组(Log-Rank x2=15.440、21.390,P均<0.001);TNM分期ⅢA期、淋巴结转移、DTX2阳性、PHF12阳性是肺腺癌患者预后不良的独立危险因素[HR(95%CI)=1.330(1.091~1.621),1.297(1.070~1.572),1.354(1.041~1.761),1.288(1.040~1.595)].结论 DTX2和PHF12在肺腺癌中表达上调,且其表达水平与TNM分期和淋巴结转移显著相关,提示二者可作为潜在的肺腺癌预后生物标志物.
Objective To study the expression of Deltex E3 ubiquitin ligase 2(DTX2)and PHD finger protein 12(PHF12)in lung adenocarcinoma and their relationship with clinicopathological features and prognosis.Methods Clinical da-ta of 98 patients with lung adenocarcinoma admitted to the Department of Oncology of Tongchuan People's Hospital from February 2020 to February 2022 were selected.R language was used to analyze the expression of DTX2 mRNA and PHF12 mRNA in the TCGA database.The expression of DTX2 mRNA/protein and PHF12 mRNA/protein was verified by quantitative real-time PCR and immunohistochemistry.Kaplan-Meier survival analysis and Cox regression analysis were used to evaluate the impact of DTX2 and PHF12 expression on the prognosis of lung adenocarcinoma.Results TCGA database analysis showed that the expression levels of DTX2 mRNA and PHF12 mRNA in lung adenocarcinoma tissues were signifi-cantly higher than those in normal lung tissues(t=16.909,14.600,both P<0.001).The expression of DTX2 mRNA was posi-tively correlated with that of PHF12 mRNA in lung adenocarcinoma tissues(r=0.566,P<0.001).qPCR results showed that the expression levels of DTX2 mRNA and PHF12 mRNA in lung adenocarcinoma tissues were(2.62±0.48)and(3.12±0.51),re-spectively,which were significantly higher than those in adjacent normal tissues(0.94±0.25,1.04±0.27)(t=30.730,35.682,both P<0.001).Immunohistochemistry results showed that the positive rates of DTX2 and PHF12 in lung adenocarcinoma tis-sues were 63.27%(62/98)and 61.22%(60/98),respectively,which were significantly higher than those in adjacent normal tis-sues(6.12%[6/98]and 5.10%[5/98])(x2=70.618,69.630,both P<0.001).The positive rates of DTX2 and PHF12 protein were significantly higher in patients with TNM stage Ⅲ A and lymph node metastasis than in those with TNM stage Ⅰ-Ⅱand without lymph node metastasis(x2/P=15.941/<0.001,19.542/<0.001;14.930/<0.001,18.382/<0.001).The 3-year progres-sion-free survival rates of patients in the DTX2-positive and PHF12-positive groups were 33.87%(21/62)and 33.33%(20/60),respectively,which were significantly lower than those in the negative groups(72.22%[26/36]and 71.05%[27/38])(Log-rank x2=15.440,21.390,both P<0.001).TNM stage Ⅲ A,lymph node metastasis,DTX2 positivity,and PHF12 positivity were independent risk factors affecting the prognosis of lung adenocarcinoma[HR(95%CI)=1.330(1.091-1.621),1.297(1.070-1.572),1.354(1.041-1.761),1.288(1.040-1.595)].Conclusion The expression of DTX2 and PHF12 is upregulated in lung adenocarcinoma and is associated with TNM stage and lymph node metastasis.These proteins may serve as novel markers for prognostic evaluation in non-small cell lung cancer.
刘婧;张妍妍;郭小军;成正祥
727000 陕西省铜川市人民医院肿瘤科727000 陕西省铜川市人民医院肿瘤科727000 陕西省铜川市人民医院肿瘤科727000 陕西省铜川市人民医院肿瘤科
医药卫生
肺腺癌Deltex E3泛素连接酶2PHD手指蛋白12预后
Lung adenocarcinomaDeltex E3 ubiquitin ligase 2PHD finger protein 12Prognosis
《疑难病杂志》 2026 (5)
530-534,5
陕西省科学技术研究发展计划(2022SF-331) Shaanxi Science and Technology Research and Development Plan(2022SF-331)
评论